Circulation Research · 1996 · 114 citations · 27 references
MedicineCardiologyPharmacologyElectrophysiologyIon Channel BiophysicsMolecular PharmacologyCardiac Ion ChannelsChannelopathiesIon Channel PharmacologyIon Channel PhysiologyIon ChannelsSodium Channel BiophysicsArrhythmogenic ChannelopathiesCardiac Ion ChannelopathiesIon Channel MutationsIon Channel SelectivitySodium Channel InactivationSodium Channel PhysiologyTransfection In Mammalian CellsVentricular Action Potentials
In transiently transfected mammalian cells we have identified pharmacological consequences of a naturally occurring deletion mutation, delta KPQ, of the human heart Na+ channel alpha subunit that previously has been linked to one form of the long QT syndrome, an inherited heart disease. Our results show that the Class IB antiarrhythmic agent lidocaine blocks maintained inward current through and slows recovery from inactivation of delta KPQ-encoded Na+ channels. Block is greater for maintained than for peak current. Because incomplete inactivation of mutant Na+ channels is now thought to underlie the prolonged ventricular action potential, which is the phenotype of this disease, and we find that the delta KPQ mutation speeds the recovery from inactivation of drug-free mutant channels, our results provide evidence, for the first time, that clinically relevant dysfunctional properties of an ion channel can be selectively targeted on the basis of the molecular properties conferred on the channel by an inherited genetic disorder.
27
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Mark Curran, Igor Splawski, Katherine W. Timothy et al. · Cell · 1995 · 2.3K citations · Full text
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Qing Wang, Jiaxiang Shen, Igor Splawski et al. · Cell · 1995 · 1.7K citations · Full text